China Biotech Services Holdings Limited (HKG:8037)

HKG:8037 Revenue

China Biotech Services Holdings had revenue of 38.87M HKD in the half year ending June 30, 2025, a decrease of -78.68%. This brings the company's revenue in the last twelve months to 76.93M, up 23.93% year-over-year. In the year 2024, China Biotech Services Holdings had annual revenue of 70.51M, down -66.74%.

• Revenue (ttm): 76.93M
• Revenue Growth: +23.93%
• P/S Ratio: 9.00
• Revenue / Employee: 578.44K
• Employees: 133
• Market Cap: 692.77M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	70.51M	-141.48M	-66.74%
Dec 31, 2023	211.99M	-1.64B	-88.55%
Dec 31, 2022	1.85B	1.23B	196.83%
Dec 31, 2021	623.76M	-32.03M	-4.88%
Dec 31, 2020	655.79M	596.58M	1,007.49%